Clinical trials
Recruiting Atherosclerosis trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Bundang Hospital | 4 |
| Yonsei University | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| CSL Behring | 1 |
| Chonnam National University Hospital | 1 |
| Eli Lilly and Company | 1 |
| Jung-min Ahn | 1 |
| Stephen Nicholls | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 13 |
| Cardiovascular Diseases | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Dyslipidemias | 4 |
| Hypercholesterolemia | 2 |
| Acute Coronary Syndrome | 1 |
| Coronary Artery Disease | 1 |
| Diabetes Mellitus | 1 |
| Kidney Failure, Chronic | 1 |
| Myocardial Infarction | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.